Dr Barber and colleagues reply

Journal of Clinical Psychiatry

Volumn 73, Issue 5, 2012, Pages 718-720

  Barber, Jacques P ^a   Barrett, Marna S ^b   Gallop, Robert ^b   Rynn, Moira A ^b,c   Rickels, Karl ^b  

^a ADELPHI UNIVERSITY   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR;

CLINICAL RESEARCH; DEPRESSION; DRUG EFFICACY; EFFECT SIZE; HUMAN; INTERMETHOD COMPARISON; LETTER; PRIORITY JOURNAL; PSYCHODYNAMICS; PSYCHOTHERAPY; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; SHORT TERM DYNAMIC PSYCHOTHERAPY; SUPPORTIVE EXPRESSIVE THERAPY;

EID: 84861828550     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12lr07633a     Document Type: Letter

References (14)

1. Barber JP, Barrett MS, Gallop R, et al. Short-term dynamic psychotherapy versus pharmacotherapy for major depressive disorder: a randomized, placebo-controlled trial. J Clin Psychiatry. 2012;73(1):66-73. doi:10.408/JCP.1m06831 PubMed
2. Luborsky L. Principles of Psychoanalytic Psychotherapy: Manual for Supportive-Expressive Treatment. New York, NY: Basic Books; 1984.
3. Fournier JC, DeRubeis RJ, Hollon SD, et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47-53. doi:10.101/jama.209.1943 PubMed
4. Kirsch I, Deacon BJ, Huedo-Medina TB, et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5(2):e45. doi:10.1371/journal.pmed.05045 PubMed
5. Khan A, Leventhal RM, Khan SR, et al. Severity of depression and response to antidepressants and placebo: an analysis of the Food and Drug Administration database. J Clin Psychopharmacol. 2002;22(1):40-45. doi:10.1097/04714-202020-07 PubMed (Pubitemid 34101291)
6. Turner EH, Matthews AM, Linardatos E, et al. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260. doi:10.1056/NEJMsa06579 PubMed
7. Walsh BT, Seidman SN, Sysko R, et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA. 2002;287(14):1840- 1847. doi:10.101/jama.287.14.1840 PubMed (Pubitemid 34303629)
8. Leichsenring F, Rabung S, Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 2004;61(12):1208-1216. PubMed (Pubitemid 39602837)
9. Driessen E, Cuijpers P, de Maat SC, et al. The efficacy of short-term psychodynamic psychotherapy for depression: a meta-analysis. Clin Psychol Rev. 2010;30(1):25-36. doi:10.1016/j.cpr.209.08.010 PubMed
10. Barber JP, Muran JC, McCarthy KS, et al. Research on psychodynamic therapies. In: Lambert MJ, ed. Bergin and Garfield's Handbook of Psychotherapy and Behavior Change. 6th ed. New York, NY: John Wiley & Sons, Inc. In press.
11. Kocsis JH. Questions raised by the failure of a trial of short-term psychodynamic therapy versus pharmacotherapy for major depressive disorder. J Clin Psychiatry. 2012;73(1):64-65. doi:10.408/JCP.1com07056 PubMed
12. Shedler J. The efficacy of psychodynamic psychotherapy. Am Psychol. 2010;65(2):98-109. doi:10.1037/a018378 PubMed
13. Westen D, Novotny CM, Thompson-Brenner H. The empirical status of empirically supported psychotherapies: assumptions, findings, and reporting in controlled clinical trials. Psychol Bull. 2004;130(4):631-663. doi:10.1037/03-2909.130.4.631 PubMed (Pubitemid 38882639)
14. Barber JP, Muenz LR. The role of avoidance and obsessiveness in matching patients to cognitive and interpersonal psychotherapy: empirical findings from the treatment for depression collaborative research program. J Consult Clin Psychol. 1996;64(5):951-958. doi:10.1037/02-06X.64.5.951 PubMed (Pubitemid 26349574)